During the past decade, Hospital Infantil de Mexico Federico Gomez conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Infantil de Mexico Federico Gomez" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Hospital Infantil de Mexico Federico Gomez" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "National Institute of Environmental Health Sciences (NIEHS)" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Infantil de Mexico Federico Gomez" #1 collaborator was "Hospital Infantil de Mexico Federico Gomez" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Centro Universitario del Sur, Guadalajara" with 1 trials as a collaborator and "Hospital Regional de Alta Especialidad del Bajio" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Infantil de Mexico Federico Gomez" are "Atopic Dermatitis" (2 trials), "Influenza A" (2 trials), "Migraine" (2 trials), "Obesity" (2 trials) and "Vitamin D Deficiency" (2 trials). Many other conditions were trialed in "Hospital Infantil de Mexico Federico Gomez" in a lesser frequency.

Most popular intervention types in "Hospital Infantil de Mexico Federico Gomez" are "Drug" (18 trials), "Biological" (3 trials), "Dietary Supplement" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Galcanezumab" (2 trials), "Lasmiditan" (2 trials), "Lebrikizumab" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Infantil de Mexico Federico Gomez" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Infantil de Mexico Federico Gomez". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Infantil de Mexico Federico Gomez, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Infantil de Mexico Federico Gomez, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".